Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goldenberg

Showing results (261-270 of 279) with videos related to

Pageof 28
Sort By:
Leukemia Research|November 26, 1999
p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycinV Lam, J P McPherson, L Salmena, et al.
BMC Public Health|December 11, 2023
Institutional trust is a distinct construct related to vaccine hesitancy and refusalSekoul Krastev, Oren Krajden, Zoua M Vang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 3, 2013
Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and ChildrenAlex R Kemper, Nancy S Green, Ned Calonge, et al.
Journal of Medicinal Chemistry|May 14, 1993
Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonistsR N Misra, B R Brown, P M Sher, et al.
Journal of Clinical and Translational Science|September 22, 2025
Usage and perceived effectiveness of recruitment techniques among clinical trials recruitersJewels Watts, Lauren Kaiser-Jackson, Bob Wong, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552D N Harris, I M Michel, H J Goldenberg, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47Joseph Weinstock, Jian Wu, Ping Cao, et al.
Science (New York, N.Y.)|May 19, 2007
Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signalingMichael B Major, Nathan D Camp, Jason D Berndt, et al.
Protein Science : a Publication of the Protein Society|April 22, 2008
Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activitiesBenjamin Nicholson, Craig A Leach, Seth J Goldenberg, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1982
Implantable insulin pump: insulin infusion in animals and manH Buchwald, W M Rupp, T D Rohde, et al.
Pageof 28

Showing results (261-270 of 279) with videos related to

Sort By:
Pageof 28
Leukemia Research|November 26, 1999
p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycinV Lam, J P McPherson, L Salmena, et al.
BMC Public Health|December 11, 2023
Institutional trust is a distinct construct related to vaccine hesitancy and refusalSekoul Krastev, Oren Krajden, Zoua M Vang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 3, 2013
Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and ChildrenAlex R Kemper, Nancy S Green, Ned Calonge, et al.
Journal of Medicinal Chemistry|May 14, 1993
Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonistsR N Misra, B R Brown, P M Sher, et al.
Journal of Clinical and Translational Science|September 22, 2025
Usage and perceived effectiveness of recruitment techniques among clinical trials recruitersJewels Watts, Lauren Kaiser-Jackson, Bob Wong, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552D N Harris, I M Michel, H J Goldenberg, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47Joseph Weinstock, Jian Wu, Ping Cao, et al.
Science (New York, N.Y.)|May 19, 2007
Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signalingMichael B Major, Nathan D Camp, Jason D Berndt, et al.
Protein Science : a Publication of the Protein Society|April 22, 2008
Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activitiesBenjamin Nicholson, Craig A Leach, Seth J Goldenberg, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1982
Implantable insulin pump: insulin infusion in animals and manH Buchwald, W M Rupp, T D Rohde, et al.
Pageof 28